You are here

• Home
• Therapy Areas
• Gastrointestinal

• An open label, multicentre study of Nexium (esomeprazole) 40 mg once daily in subjects with symptoms of Gastroesophageal Reflux Disease (GORD) after treatment with a full dose of Proton Pump Inhibitor (PPI) - NEON

Disease

gastrointestinal diseases

Drug Name

Nexium

Generic Name

esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

IV

Start Date

Nov 13, 2007

Study Name

NEON

Study Id

D9612L00116

ClinicalTrials.gov ID

NCT00734097

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 18, 1971

• D9612L00116.pdf (128 KB)

Page tools

• Print
• Bookmark this page